Kathy Boltz, PhD

All articles by Kathy Boltz, PhD

Adding SSRIs or SNRIs to Tapentadol Does Not Increase Adverse Events

Vincent Brett, MS, PharmD, of Janssen Scientific Affairs, Raritan, NJ, and colleagues presented a post-hoc analysis of pooled safety data at PAINWeek 2012, and found that adding tapentadol to selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) resulted in no clinically relevant adverse drug interactions.

PAINWeek 2012 Conference Keynote Address: The Realities of Pain as a Public Health and Social Issue

Daniel B. Carr, MD, of Tufts University School of Medicine delivered a keynote address titled “Have We Been Backwards, Upside Down, or Both?” at the opening session for PAINWeek 2012. He advocated teaching about pain by emphasizing the reality of pain as population-based, inter-subjective, and with an important moral dimension, rather than beginning by focusing on nociceptors and the biochemistry of pain. This perspective will allow students to face difficult interactions in the clinic.